AMENDED AND RESTATED EXECUTIVE Employment AgreementExecutive Employment Agreement • June 7th, 2022 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New Jersey
Contract Type FiledJune 7th, 2022 Company Industry JurisdictionThis Amended and Restated Executive Employment Agreement dated as of June 2, 2022 (“Agreement”) is by and between Lawrence A. Kenyon (“Executive”) and Outlook Therapeutics, Inc. (“Company”).